# China Antihypertensive Trial in Acute Ischemic Stroke II

Study · id `cardio:ct-nct03479554` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03479554](<https://clinicaltrials.gov/study/NCT03479554>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03479554

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 4810 participants.

## Technical summary

Registry record NCT03479554. Randomized; double masking; primary purpose treatment. Start 2018-06-13 (actual); primary completion 2022-10-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 4810 participants (enrolled count; ClinicalTrials.gov record NCT03479554, source copy `cardio:ctgov-nct03479554-2023-08-01`, retrieved 2026-10-26)
- Started: 2018-06-13 (actual) (ClinicalTrials.gov record NCT03479554, source copy `cardio:ctgov-nct03479554-2023-08-01`, retrieved 2026-10-26)
- Primary completion: 2022-10-15 (actual) (ClinicalTrials.gov record NCT03479554, source copy `cardio:ctgov-nct03479554-2023-08-01`, retrieved 2026-10-26)
- Completion: 2023-01-15 (actual) (ClinicalTrials.gov record NCT03479554, source copy `cardio:ctgov-nct03479554-2023-08-01`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03479554, source copy `cardio:ctgov-nct03479554-2023-08-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03479554-2023-08-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: China Antihypertensive Trial in Acute Ischemic Stroke II
- Acronym: CATIS-2
- Condition: Acute Ischemic Stroke
- Intervention (Other): Early antihypertensive treatment
- Intervention (Other): Delayed antihypertensive treatment
- Lead sponsor: Tulane University
- Lead sponsor class: OTHER
- Collaborator: Beijing Tiantan Hospital
- Collaborator class: OTHER
- Collaborator: Soochow University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Tulane University (`cardio:org-tulane-university`)
- Registry lists this organization as a collaborator: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial (`cardio:pubmed-37813418`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Early vs Delayed Antihypertensive Treatment in Acute Single Subcortical Infarction: A Secondary Analysis of the CATIS-2 Randomized Clinical Trial (`cardio:pubmed-39212990`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Early Versus Delayed Antihypertensive Treatment After Acute Ischemic Stroke by Hypertension History (`cardio:pubmed-39807580`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Initial systolic blood pressure, antihypertensive treatment timing and outcomes in acute ischemic stroke: a subgroup analysis of CATIS-2 trial (`cardio:pubmed-41860186`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: aed6467fd127ac5c970505edb15bdc2d6148ec8973aedb3a88fecfd7153982d0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
